BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 16503857)

  • 1. Radiotherapeutic management of locally advanced head and neck cancer.
    Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
    Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
    Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
    Bernier J; Cooper JS
    Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Krstevska V
    J BUON; 2009; 14(3):361-73. PubMed ID: 19810125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modalities in the treatment of head and neck cancers.
    Aisner J; Hiponia D; Conley B; Jacobs M; Gray W; Belani CP
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):28-34. PubMed ID: 7541154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer.
    Airoldi M; Cortesina G; Giordano C; Pedani F; Gabriele AM; Marchionatti S; Bumma C
    Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):161-6. PubMed ID: 14967744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.
    Matzinger O; Zouhair A; Mirimanoff RO; Ozsahin M
    Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):525-31. PubMed ID: 19535232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for head and neck cancer: progress and controversy in the management of patients with M0 disease.
    Clark JR; Frei E
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):44-57. PubMed ID: 2669137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
    Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging standards of concomitant chemoradiotherapy.
    Adelstein DJ; Rodriguez CP
    Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
    Vokes EE; Haraf DJ; Kies MS
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidermoid carcinoma of the head and neck: contribution of chemotherapy in case of recurrence and locally advanced disease. Review of the literature].
    Hasbini A; Durdux C; Faivre S; Wasserman E; Taamma A; Armand JP; Raymond E; Cvitkovic E
    Ann Otolaryngol Chir Cervicofac; 2000 Dec; 117(6):390-402. PubMed ID: 11148344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
    Dietl B; Marienhagen J; Schäfer C; Kölbl O
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy: emerging treatment improvement strategies.
    Milas L; Mason KA; Liao Z; Ang KK
    Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
    J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.